Search research articles
Contact Us
Filters
Showing results (11-20 of 99) with videos related to
Page
of 10
Sort By:
Clinical Nuclear Medicine
|
March 20, 2019
Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007
Robert Seifert, Darius Schafigh, Martin Bögemann, et al.
Cancers
|
March 14, 2026
Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer
Kambiz Rahbar, Martin Bögemann, Philipp Papavasilis, et al.
Clinical Nuclear Medicine
|
December 7, 2016
Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CT
Wolfgang Roll, Axel Bode, Matthias Weckesser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 31, 2019
A Self-Fulfilling Prophecy: Comparing <sup>177</sup>Lu-PSMA Radioligand Therapy in Taxane-Naïve Versus Posttaxane Metastasized Prostate Cancer Patients?
Kambiz Rahbar, Michael S Hofman, Andres J Schrader, et al.
Clinical Nuclear Medicine
|
July 24, 2018
Long-term Survival and Excellent Response to Repeated 177Lu-Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate Cancer
Wolfgang Roll, Axel Bräuer, Matthias Weckesser, et al.
Clinical Nuclear Medicine
|
November 8, 2016
Benefit of 68Ga-PSMA-PET/CT in Patients Considered for 223Ra-Dichloride Therapy
Axel Bode, Kambiz Rahbar, Julia Konnert, et al.
Aktuelle Urologie
|
August 22, 2023
[Emergencies in cancer immunotherapy]
Analena Handke, Thomas Hilser, Martin Bögemann, et al.
Nuklearmedizin. Nuclear Medicine
|
July 11, 2022
Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement
Daniel Alexander Hescheler, Lars Stegger, Katrin Schlack, et al.
Urologia Internationalis
|
September 29, 2020
Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany
Martin Bögemann, Aleksandra Zagorska, Divine Akumo, et al.
Cancers
|
October 27, 2022
Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [<sup>18</sup>F]F-PSMA 1007 PET
Elisabeth Relt, Wolfgang Roll, Michael Claesener, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 99) with videos related to
Sort By:
Page
of 10
Clinical Nuclear Medicine
|
March 20, 2019
Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007
Robert Seifert, Darius Schafigh, Martin Bögemann, et al.
Cancers
|
March 14, 2026
Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer
Kambiz Rahbar, Martin Bögemann, Philipp Papavasilis, et al.
Clinical Nuclear Medicine
|
December 7, 2016
Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CT
Wolfgang Roll, Axel Bode, Matthias Weckesser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 31, 2019
A Self-Fulfilling Prophecy: Comparing <sup>177</sup>Lu-PSMA Radioligand Therapy in Taxane-Naïve Versus Posttaxane Metastasized Prostate Cancer Patients?
Kambiz Rahbar, Michael S Hofman, Andres J Schrader, et al.
Clinical Nuclear Medicine
|
July 24, 2018
Long-term Survival and Excellent Response to Repeated 177Lu-Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate Cancer
Wolfgang Roll, Axel Bräuer, Matthias Weckesser, et al.
Clinical Nuclear Medicine
|
November 8, 2016
Benefit of 68Ga-PSMA-PET/CT in Patients Considered for 223Ra-Dichloride Therapy
Axel Bode, Kambiz Rahbar, Julia Konnert, et al.
Aktuelle Urologie
|
August 22, 2023
[Emergencies in cancer immunotherapy]
Analena Handke, Thomas Hilser, Martin Bögemann, et al.
Nuklearmedizin. Nuclear Medicine
|
July 11, 2022
Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement
Daniel Alexander Hescheler, Lars Stegger, Katrin Schlack, et al.
Urologia Internationalis
|
September 29, 2020
Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany
Martin Bögemann, Aleksandra Zagorska, Divine Akumo, et al.
Cancers
|
October 27, 2022
Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [<sup>18</sup>F]F-PSMA 1007 PET
Elisabeth Relt, Wolfgang Roll, Michael Claesener, et al.
Page
of 10